Diagnos Inc.

Diagnos Inc.

December 15, 2008 14:12 ET

DIAGNOS Acquires Four New Mining Properties in the Gaspesie Region

BROSSARD, QUEBEC--(Marketwire - Dec. 15, 2008) - DIAGNOS inc. ("DIAGNOS" or the "Corporation") (TSX VENURE:ADK), a leader in the use of artificial intelligence ("AI") and advanced knowledge extraction techniques, announced today that it has acquired four new properties based on the interpretation of a database acquired from the Quebec government for the Gaspesie region. As a result of this interpretation, covering approximately 20,000 km2, the Corporation has chosen to pursue its strategy initiated in other regions.

DIAGNOS uses CARDS in an efficient way that allies expertise in artificial intelligence and the knowledge of our team in geology and geophysics. These combined efforts resulted in an analysis of millions of data points with more than 30 layers of information per points.

These properties are located in the South-Western part of the Gaspesie region close to St-Andre-de-Restigouche. The sector presents anomalies and showings in copper and gold that are of interest for exploration. These newly acquired properties consist of 267 claims, including the previous claims held by DIAGNOS in the region. The four properties are located at the junction of two formations that are associated to mineralization. Furthermore, the structural environment is favourable to findings of economical values for gold and base metals. Claims are located close to a major fault oriented NE-SW, which is a prolongation of Grand Pabos fault.

DIAGNOS is currently in negotiation with several mining exploration companies for partnerships on these properties.

DIAGNOS can count on a multidisciplinary team that includes professionals in geophysics, geology, Artificial Intelligence, mathematics, as well as remote sensing and image interpretation. The Corporation's objective is to develop a royalty stream by significantly enhancing and participating in the exploration success rate of mining and oil and gas companies. For further information, please visit our Website at www.diagnos.com.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information